MedTrace Logo

Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules

NCT06307132 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-03-12

No results posted yet for this study

Summary

This project will be based on the bioequivalence test of Aximus capsules, measuring the body composition indicators of healthy subjects before and after medication, and collecting urine samples from subjects at different time periods after medication, measuring urine drug concentration, calculating urine excretion, analyzing the individualized differences in metabolism and excretion of Aximus capsules under different health states of human components, and providing guidance for clinical precision medication.

Conditions

  • Bioequivalence Trial

Interventions

OTHER

Aximus capsules（test）

Aximus capsules test preparation

DRUG

Aximus capsules（reference）

Aximus capsules reference preparation

Sponsors & Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Ting Li, Master · Second Affiliated Hospital of Wenzhou Medical University

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-06-30
Completion
2024-08-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06307132 on ClinicalTrials.gov